News
Cancer Immunotherapy 'Uniquely Suppressed' by Liver Tumors
Though cancer immunotherapy has become a promising standard-of-care treatment—and in some cases, perhaps a cure—for a wide variety of different cancers, it doesn’t work for everyone, and researchers have increasingly turned their attention to understanding why. For example, doctors have noticed that
Immense Variation Found Within Meningiomas Offers Insight Into Therapeutic Targets
With 34,210 new diagnoses projected this year in the United States, 1 meningiomas are the most common primary brain tumor. While the majority of meningiomas are low grade and typically respond well to surgery and radiotherapy, high grade meningiomas are still poorly understood and often recur
Alain Algazi and Team Run "Absurd" Marathon Course to Benefit American Cancer Society
On October 4th, Alain Algazi, MD, a melanoma specialist and head-and-neck cancer researcher at UCSF, will join friends and colleagues in running a marathon across SF and Marin to benefit the American Cancer Society. The ambitious 26.5 mile course will begin at the Hi Dive Bar under the Bay Bridge
UCSF's CMO of Cancer Services Plea to Patients
As we continue to cope with the ongoing coronavirus pandemic nationwide, a second public health crisis is emerging and causing increasing alarm. Stemming from the initial deferrals of routine care as the pandemic took hold, combined with shelter-in-place health orders and the fears generated by
Mapping Genetic Diversity of Lung Tumors Over Time May Lead to More Effective Therapies
A malignant tumor is a bustling metropolis populated by many different kinds of cancer cells. This cellular diversity, however, is what makes cancer so difficult to treat, as each type of cell in a tumor responds differently – and sometimes not at all – to cancer therapies. This is especially true
Oncologists: Chadwick Boseman's death from colon cancer at 43 underscores a disturbing trend
By Sorbarikor Piawah, Gabriel A. Brooks and Franklin W. Huang | SF Chronicle | Sep. 3, 2020 News of Chadwick Boseman’s private struggle and tragic death from colon cancer at the age of 43 has been especially jarring to the medical community, as it highlights an alarming trend. While colon cancer
Danica Fujimori Receives $1.25M Bowes Biomedical Investigator Award
UC San Francisco chemical biologist Danica Galonić Fujimori, PhD, has been named this year’s Bowes Biomedical Investigator. The award provides unrestricted funding of $1.25 million over five years to support Fujimori’s teaching and leadership roles and advance her quest to understand life’s